Navigating The Storm: Key challenges for pharmaceutical manufacturers in an evolving US market

Jamie Van Iderstine leads a team of market access experts who deliver innovative and impactful solutions for pharmaceutical and biotech clients. She leverages her 15 years of experience in marketing and consulting to oversee client engagement and market access strategy for large agency-of-record accounts, as well as project-based engagements.

Jamie has a deep and nuanced understanding of the highly complex and rapidly evolving reimbursement landscape, with a focus on immunology, rare diseases, rare blood disorders, pulmonology, and behavioral health. She has extensive work across payer channels, including Commercial, Medicare, Medicaid, and other market access stakeholders. She has expertise in payer segmentation, payer engagement, pricing and contracting, and other strategic disciplines.

Kartin Sood brings more than 15 years of experience in the life sciences industry, guiding pharmaceutical and biotech companies through complex market access and policy challenges. She has shaped innovative access models across high impact therapeutic areas including cardiovascular, metabolic, immunology, infectious diseases, and women’s health, with a particular focus on reproductive health and oncology.

Her expertise spans early pipeline planning, portfolio strategy, pricing and contracting, and policy impact analysis. Kartin works closely with clients to evaluate how evolving policies affect drug pricing, rebates, coverage decisions, and investment priorities. She translates these dynamics into strategies that maximize coverage for patient populations and ensure sustainable reimbursement throughout the product life cycle.